We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ABIO market cap is 49.74M. The company's latest EPS is USD -0.3682 and P/E is -9.32.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.55M | -1.8M | -1.97M | -1.94M | -1.59M |
| Net Income | -1.17M | -1.35M | -1.48M | -1.42M | -1.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.81M | -9.77M | -19.34M | -10.6M | -7.3M |
| Net Income | -5.48M | -9.74M | -19.32M | -9.93M | -5.34M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.09M | 42.06M | 41.08M | 39.18M | 37.86M |
| Total Liabilities | 1.41M | 1.53M | 1.85M | 1.22M | 841k |
| Total Equity | 41.67M | 40.53M | 39.24M | 37.97M | 37.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.54M | 50.43M | 54.92M | 43.09M | 37.86M |
| Total Liabilities | 926k | 3.91M | 3.88M | 1.41M | 841k |
| Total Equity | 7.61M | 46.52M | 51.04M | 41.67M | 37.02M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.91M | -1.6M | -2.29M | -3.96M | -5.01M |
| Investing | -2k | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.8M | -7.73M | -18.76M | -10.91M | -5.01M |
| Investing | -4k | -19k | -43k | -2k | N/A |
| Financing | 6.56M | 48.45M | 23.09M | N/A | N/A |
| Market Cap | 49.74M |
| Price to Earnings Ratio | -9.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.33 |
| Price to Book Ratio | 1.34 |
| Dividend Yield | - |
| Shares Outstanding | 14.5M |
| Average Volume (1 week) | 134.63k |
| Average Volume (1 Month) | 4.43M |
| 52 Week Change | 75.00% |
| 52 Week High | 3.88 |
| 52 Week Low | 1.56 |
| Spread (Intraday) | 0.47 (12.57%) |
| Company Name | ARCA Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.arcabio.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
